Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-066143

CONCERT PHARMACEUTICALS, INC. · CNCE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Aug 12, 2015
Accepted (ET)
Aug 14, 2015 · 5:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Aug 12, 2015S46,398$14.4897D493,977ISee Footnote
Common StockF2Aug 12, 2015S2,494$14.4897D26,558ISee Footnote
Common StockF3Aug 12, 2015S47,837$14.4897D509,289ISee Footnote
Common StockF4Aug 12, 2015S1,056$14.4897D11,245ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

Following the transaction reported in this Form 4, Wilfred Jaeger, as a director of the Issuer, will remain subject to Section 16.